Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
XPro1595
Description:
XPro1595 is an investigational biologic drug that selectively inhibits soluble tumor necrosis factor for research and treatment of inflammatory conditions.
Related topics:
Alzheimer's disease research and treatments (18%),
Neuroinflammation and Neurodegeneration Mechanisms (15%),
Spinal Cord Injury Research (9%)
OpenAlex ID:
keywords/xpro1595
Inhibition of soluble tumour necrosis factor is therapeutic in experimental autoimmune encephalomyelitis and promotes axon preservation and remyelination
2011
·
Roberta Brambilla
, Jessica Jopek Ashbaugh
, et al.
·
Brain
·
231
PDF
Peripheral administration of the soluble TNF inhibitor XPro1595 modifies brain immune cell profiles, decreases beta-amyloid plaque load, and rescues impaired long-term potentiation in 5xFAD mice
2017
·
Kathryn P. MacPherson
, Pradoldej Sompol
, et al.
·
Neurobiology of Disease
·
171
Oligodendroglial TNFR2 Mediates Membrane TNF-Dependent Repair in Experimental Autoimmune Encephalomyelitis by Promoting Oligodendrocyte Differentiation and Remyelination
2016
·
Pernille M. Madsen
, Dario Motti
, et al.
·
Journal of Neuroscience
·
167
PDF
Toll-like Receptor 4 Mediates Morphine-Induced Neuroinflammation and Tolerance via Soluble Tumor Necrosis Factor Signaling
2016
·
Lori N Eidson
, Kiyoshi Inoue
, et al.
·
Neuropsychopharmacology
·
147
PDF
Inhibition of soluble tumor necrosis factor is therapeutic in Huntington's disease
2014
·
Han-Yun Hsiao
, Feng-Lan Chiu
, et al.
·
Human Molecular Genetics
·
147
Soluble Tumor Necrosis Factor Alpha Promotes Retinal Ganglion Cell Death in Glaucoma via Calcium-Permeable AMPA Receptor Activation
2015
·
Jorge L. Cueva Vargas
, Ingrid K. Osswald
, et al.
·
Journal of Neuroscience
·
145
PDF
Targeting soluble tumor necrosis factor as a potential intervention to lower risk for late-onset Alzheimer’s disease associated with obesity, metabolic syndrome, and type 2 diabetes
2019
·
Maria Elizabeth De Sousa Rodrigues
, Madelyn C. Houser
, et al.
·
Alzheimer s Research & Therapy
·
144
PDF
Peripheral Administration of the Selective Inhibitor of Soluble Tumor Necrosis Factor (TNF) XPro®1595 Attenuates Nigral Cell Loss and Glial Activation in 6-OHDA Hemiparkinsonian Rats
2014
·
Christopher J. Barnum
, Xi Chen
, et al.
·
Journal of Parkinson s Disease
·
138
Chronic dim light at night provokes reversible depression-like phenotype: possible role for TNF
2012
·
T A Bedrosian
, Z M Weil
, et al.
·
Molecular Psychiatry
·
124
Systemically administered anti-TNF therapy ameliorates functional outcomes after focal cerebral ischemia
2014
·
Bettina Clausen
, Matilda Degn
, et al.
·
Journal of Neuroinflammation
·
117
PDF
Therapeutic inhibition of soluble brain TNF promotes remyelination by increasing myelin phagocytosis by microglia
2017
·
Maria Karamita
, Christopher Barnum
, et al.
·
JCI Insight
·
112
PDF
Inhibiting tumor necrosis factor-α before amyloidosis prevents synaptic deficits in an Alzheimer's disease model
2016
·
Chelsea Cavanagh
, Yiu Chung Tse
, et al.
·
Neurobiology of Aging
·
90
PDF
Central but not systemic administration of XPro1595 is therapeutic following moderate spinal cord injury in mice
2014
·
Hans G Novrup
, Valerie Bracchi-Ricard
, et al.
·
Journal of Neuroinflammation
·
76
PDF
Effects of early life stress on cocaine conditioning and AMPA receptor composition are sex-specific and driven by TNF
2019
·
Prabarna Ganguly
, Jennifer A. Honeycutt
, et al.
·
Brain Behavior and Immunity
·
65
PDF
Soluble TNFα Signaling within the Spinal Cord Contributes to the Development of Autonomic Dysreflexia and Ensuing Vascular and Immune Dysfunction after Spinal Cord Injury
2018
·
Eugene Mironets
, Patrick Osei-Owusu
, et al.
·
Journal of Neuroscience
·
62
PDF
Inhibition of Soluble Tumor Necrosis Factor Ameliorates Synaptic Alterations and Ca2+ Dysregulation in Aged Rats
2012
·
Diana M. Sama
, Hafiz Mohmmad Abdul
, et al.
·
PLoS ONE
·
61
PDF
Microglia, inflammation and gut microbiota responses in a progressive monkey model of Parkinson's disease: A case series
2020
·
Valerie Joers
, Gunasingh Masilamoni
, et al.
·
Neurobiology of Disease
·
56
PDF
Transmembrane TNF–TNFR2 Impairs Th17 Differentiation by Promoting Il2 Expression
2015
·
Patrick G Miller
, Michael B Bonn
, et al.
·
The Journal of Immunology
·
54
Tumor necrosis factor receptor 1 inhibition is therapeutic for neuropathic pain in males but not in females
2018
·
Tania del Rivero
, Roman Fischer
, et al.
·
Pain
·
53
Tumor Necrosis Factor Suppresses NR5A2 Activity and Intestinal Glucocorticoid Synthesis to Sustain Chronic Colitis
2014
·
Sheng-Chieh Huang
, Cheng-tse Lee
, et al.
·
Science Signaling
·
44
TNF deficiency causes alterations in the spatial organization of neurogenic zones and alters the number of microglia and neurons in the cerebral cortex
2019
·
Minna Yli-Karjanmaa
, Kathrine Solevad Larsen
, et al.
·
Brain Behavior and Immunity
·
43
PDF
Attenuating Neurogenic Sympathetic Hyperreflexia Robustly Improves Antibacterial Immunity After Chronic Spinal Cord Injury
2019
·
Eugene Mironets
, Roman Fischer
, et al.
·
Journal of Neuroscience
·
39
Topical Administration of a Soluble TNF Inhibitor Reduces Infarct Volume After Focal Cerebral Ischemia in Mice
2019
·
Minna Yli-Karjanmaa
, Bettina Hjelm Clausen
, et al.
·
Frontiers in Neuroscience
·
39
PDF
Inhibition of Soluble Tumor Necrosis Factor Prevents Chemically Induced Carcinogenesis in Mice
2016
·
Andrea Sobo-Vujanovic
, Lazar Vujanovic
, et al.
·
Cancer Immunology Research
·
39
Inhibition of soluble TNFα prevents adverse atrial remodeling and atrial arrhythmia susceptibility induced in mice by endurance exercise
2019
·
Robert Lakin
, Nazari Polidovitch
, et al.
·
Journal of Molecular and Cellular Cardiology
·
36
Show more works
View as search
Works count:
94
Citation count:
2,697
Year
Topic
Type